CatSci Ltd is an award-winning innovation partner for the development and manufacture of new medicines. We work seamlessly with our global customers to solve their analytical chemistry challenges with speed and scientific integrity by applying the right science at the right time.
Our highly-qualified technical team, state-of-the-art analytical equipment and collaboration with Shimadzu, the leading experts in cannabinoid analysis, mean that we can deliver the highest quality analytical testing on cannabinoids. We aim to build a comprehensive cannabinoids capability that includes potency, related substances measurement, impurity identification, terpenes, pesticides and heavy metals. We are currently working to GMP principles with a full quality management system and aim to be GMP certified in 2023. CatSci is seeking to build relationships and collaborations with CBD medicinal products producers to accelerate GMP certification, ensuring quality of products for patients.
Ensuring open consultation and communication with our customers built on trust and transparency we proactively respond to their ever-evolving needs now and in the future. We pride ourselves in using our passion for solving multi-disciplinary problems and commitment to innovative thinking to add strategic value to our customers’ projects.
Recent recognition includes the highly esteemed Queen’s Award for Enterprise: International Trade 2022, the 2022 Bionow Awards (Export of the Year), the 2022 Inspire Business Awards (Business of the Year (25+ employees)), the 2022 Wales Business Awards (Workplace Wellbeing), the 2022 Wales STEM Awards (STEM Company of the Year (50+ Employees) and STEM Ambassador of the Year), and the 2022 Cardiff Business Award (International Business of the Year).